Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 11/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 7/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27256683 | 0.99 | PREP (0.50) | PREPPSMB5F2ITGB3ITGA2B | |
| SCHEMBL25892014 | 0.92 | PREP (0.46) | PREPPSMB5F2ITGB3ITGA2B | |
| SCHEMBL12658549 | 0.90 | PREP (0.53) | PREPPSMB5F2 | |
| SCHEMBL8234287 | 0.86 | PREP (0.56) | PREPPSMB5F2 | |
| SCHEMBL16079844 | 0.85 | PREP (0.55) | PREPPSMB5F2 | |
| SCHEMBL24025130 | 0.84 | PREP (0.54) | PREPPSMB5F2 | |
| SCHEMBL14161094 | 0.84 | PREP (0.54) | PREPPSMB5 | |
| SCHEMBL21156219 | 0.84 | PREP (0.54) | PREPPSMB5F2 | |
| SCHEMBL14161093 | 0.84 | PREP (0.54) | PREPPSMB5 | |
| SCHEMBL25890366 | 0.83 | PREP (0.59) | PREPF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207292-A1 | BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS | TRUSTEES OF TUFTS COLLEGE | 2024-06-27 | — | — | US | disclosed |
| US-20230330275-A1 | FAP-TARGETED RADIOPHARMACEUTICALS AND IMAGING AGENTS, AND USES RELATED THERETO | TRUSTEES OF TUFTS COLLEGE | 2023-10-19 | — | — | US | disclosed |
| US-11707539-B2 | FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto | TRUSTEES OF TUFTS COLLEGE (US) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230330275-A1 | FAP-TARGETED RADIOPHARMACEUTICALS AND IMAGING AGENTS, AND USES RELATED THERETO | FAP, APC, FIBP | PREP 543/4885PSMB5 1463/4885F2 3397/4885 |
| US-11707539-B2 | FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto | FAP, APC, FIBP | PREP 543/4885PSMB5 1463/4885F2 3397/4885 |
| US-20240207292-A1 | BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS | BCL6B, BCL6, BTD | PREP 2680/4885PSMB5 1532/4885F2 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.